LUND, SWEDEN--(MARKET WIRE)--Aug 10, 2007 -- The review of Active Biotech’s IND (Investigational New Drug) for the TASQ prostate cancer project has been completed by the US Food and Drug Administration (FDA).
LUND, SWEDEN--(MARKET WIRE)--Aug 10, 2007 -- The review of Active Biotech’s IND (Investigational New Drug) for the TASQ prostate cancer project has been completed by the US Food and Drug Administration (FDA).
